We narrowed to 8 results for: sequence

1. AAV-GfaABC1D-Cre-4x6T (AAV5)

   Viral Prep

   #196410-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from AAV-GfaABC1D-Cre-4x6T (#196410). In addition to the viral particles, you will also receive purified AAV-GfaABC1D-Cre-4x6T plasmid DNA. GfaABC1D driven expression of Cre recombinase in astrocytes. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Stanley Thomas Carmichael

   Article

   Gleichman et al Nat Commun. 2023 Nov 16;14(1):7426. doi:

   Promoter

   CAG and GfaABC1D

   Tags

   None

   Available Since

   Sept. 27, 2024

   Availability

   Academic Institutions and Nonprofits only

2. pAAV-CBh-mKate2-IRES-MCS (WT-WT) (AAV2)

   Viral Prep

   #105921-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-CBh-mKate2-IRES-MCS (WT-WT) (#105921). In addition to the viral particles, you will also receive purified pAAV-CBh-mKate2-IRES-MCS (WT-WT) plasmid DNA. Control mKate2 expression AAV with two wild-type ITR sequences. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Marcella Patrick

   Promoter

   CBh and same CBh promoter as mKate2

   Tags

   mKate2

   Available Since

   Nov. 13, 2018

   Availability

   Academic Institutions and Nonprofits only

3. pAAV-hSynapsin-FLEX-soCoChR-GFP (AAV9)

   Viral Prep

   #107712-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSynapsin-FLEX-soCoChR-GFP (#107712). In addition to the viral particles, you will also receive purified pAAV-hSynapsin-FLEX-soCoChR-GFP plasmid DNA. Synapsin-driven, Cre-dependent somatic CoChR (soCoChR) fused to GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Shemesh et al Nat Neurosci. 2017 Dec;20(12):1796-1806.

   Promoter

   Syn

   Tags

   GFP (Cre-dependent)

   Available Since

   Sept. 7, 2018

   Availability

   Academic Institutions and Nonprofits only

4. pAAV-hSynapsin- soCoChR-GFP (AAV9)

   Viral Prep

   #107708-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV-hSynapsin- soCoChR-GFP (#107708). In addition to the viral particles, you will also receive purified pAAV-hSynapsin- soCoChR-GFP plasmid DNA. Synapsin-driven somatic CoChR (soCoChR) fused to GFP for optogenetic activation. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Shemesh et al Nat Neurosci. 2017 Dec;20(12):1796-1806.

   Promoter

   Syn

   Tags

   GFP

   Available Since

   Sept. 7, 2018

   Availability

   Academic Institutions and Nonprofits only

5. pAAV.cTNT.iCre (AAV9)

   Viral Prep

   #69916-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.cTNT.iCre (#69916). In addition to the viral particles, you will also receive purified pAAV.cTNT.iCre plasmid DNA. cTnT driven in vivo expression of Cre and tdTomato (separated by IRES sequence). These AAV preparations are suitable purity for injection into animals.

   Depositor

   William Pu

   Article

   Lin et al Circ Res. 2015 Jan 2;116(1):35-45. doi:

   Promoter

   Chicken cardiac troponin T

   Tags

   tdTomato

   Available Since

   July 31, 2025

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-hsyn-flex-Voltron-ST (AAV1)

   Viral Prep

   #119036-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV-hsyn-flex-Voltron-ST (#119036). In addition to the viral particles, you will also receive purified pAAV-hsyn-flex-Voltron-ST plasmid DNA. Synapsin-driven, cre-dependent expression of genetically encoded fluorescent voltage indicator Voltron1 with a soma-targeting sequence. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Eric Schreiter

   Article

   Abdelfattah et al Science. 2019 Aug 1. pii: science.aav641

   Promoter

   Syn

   Tags

   None

   Available Since

   April 10, 2019

   Availability

   Academic Institutions and Nonprofits only

7. pGP-AAV-syn-FLEX-Volton2-ST-WPRE (AAV1)

   Viral Prep

   #172907-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pGP-AAV-syn-FLEX-Volton2-ST-WPRE (#172907). In addition to the viral particles, you will also receive purified pGP-AAV-syn-FLEX-Volton2-ST-WPRE plasmid DNA. Cre-dependent, Syn-driven expression of the voltage sensor Voltron2-ST containing a soma localization targeting sequence. These AAV preparations are suitable purity for injection into animals.

   Depositor

   GENIE Project

   Article

   Abdelfattah et al Neuron. 2023 Mar 28:S0896-6273(23)00205-

   Promoter

   Syn

   Tags

   None

   Available Since

   July 21, 2023

   Availability

   Academic Institutions and Nonprofits only

8. AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) (AAV PHP.eB)

   Viral Prep

   #163505-PHPeB

   Purpose

   Ready-to-use AAV PHP.eB particles produced from AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) (#163505). In addition to the viral particles, you will also receive purified AiP11390-pAAV-DLX2.0-minBG-SYFP2-WPRE3-BGHpA (Alias: CN1390) plasmid DNA. AAV vector for strong and rapid SYFP2 expression in forebrain GABAergic interneurons. The enhancer core sequence has 100% sequence conservation between mouse and human. Developed especially for rapid viral labeling in human and NHP organotypic brain slice culture. These AAV were produced with the PHPeB serotype, which permits efficient transduction of the central nervous system. These AAV preparations are suitable purity for injection into animals.

   Depositor

   The Allen Institute for Brain Science, Jonathan Ting

   Article

   Ben-Simon et al Cell. 2025 May 16:S0092-8674(25)00513-6.

   Promoter

   minBetaGlobin

   Tags

   SYFP2

   Available Since

   Aug. 17, 2022

   Availability

   Academic Institutions and Nonprofits only